the Shinetsu Chemical Industry. All were used without further
purification for the preparation of the corresponding silyl enol
ethers. 1-Trimethylsilyloxy-1-phenylethene 2a from Aldrich
Chemicals was used without further purification. Methanesul-
fonyl chloride from Wako Chemicals and pentafluorobenzene-
sulfonyl chloride from Hydrus Chemicals were used without
further purification. Toluene-p-sulfonyl chloride from Wako
Chemicals was recrystallized from hexane prior to use. Dichloro-
tris(triphenylphosphine)ruthenium() was prepared by the
method described in the literature, mp 123 ЊC.5
129.0, 129.2, 135.0, 135.1 and 187.8; δF (376 MHz, CDCl3)
135.88–136.01 (2 F, m), 142.84 (1 F, tt, J 21.3 and 7.8) and
158.27–158.43 (2 F, m); m/z 350 (M+), 287, 183 and 167 (Found:
C, 48.00; H, 1.81. Calc. for C14H7F5O3S: C, 48.01; H, 2.01%).
4-Methoxyphenacyl methyl sulfone 3d. Colourless needles;
mp 136.0–136.9 ЊC (from CH2Cl2–hexane; lit.,10 136–137 ЊC);
vmax(KBr)/cmϪ1 3150, 2960, 1670, 1600, 1330, 1310, 1270, 1190
and 1160; δH (400 MHz, CDCl3) 3.13 (3 H, s), 3.90 (3 H, s),
4.54 (2 H, s), 6.98 (2 H, d, J 8.8) and 7.98 (2 H, d, J 8.8);
δC(100 MHz, CDCl3) 41.7, 55.6, 61.1, 114.2, 128.6, 131.9, 164.8
and 187.3; m/z 229 (M+ + 1), 150, 136 and 107.
General procedures for the preparation of silyl enol ethers6 2b–f
To a solution of aryl methyl ketone (80 mmol) in DMF (32 ml)
under nitrogen was added triethylamine (19.5 g, 192 mmol)
followed by trimethylchlorosilane (10.4 g, 96 mmol). After the
solution had been refluxed and stirred for 48 h, it was extracted
with pentane (80 cm 3) and the extract was washed with a satur-
ated aqueous potassium hydrogen carbonate ( × 3), water (80
cm 3 × 3), 1.5 hydrochloric acid (80 cm 3 × 2), water (80 cm 3),
saturated aqueous potassium hydrogen carbonate (80 cm 3 × 2),
water (80 cm 3 × 2) and brine (80 cm 3). The solvent then evapor-
ated under reduced pressure and the residual oily silyl enol
ether was distilled. Yields and boiling points of silyl enol ethers
are as follows: 1-trimethylsilyloxy-1-(4Ј-methoxyphenyl)ethene
2b (50%), bp 88 ЊC/0.50 mmHg; 1-trimethylsilyloxy-1-(4Ј-
tolyl)ethene 2c (67%), bp 59–60 ЊC/0.45 mmHg; 1-trimethyl-
silyloxy-1-(4Ј-fluorophenyl)ethene 2d (59%), bp 43–46 ЊC/0.50
mmHg; 1-trimethylsilyloxy-1-(4Ј-chlorophenyl)ethene 2e (42%),
bp 54–56 ЊC/0.8 mmHg; 1-trimethylsilyloxy-1-(4Ј-nitrophenyl)-
ethene 2f (34%), bp 95–97 ЊC/0.45 mmHg.
4-Methoxyphenacyl 4Ј-tolyl sulfone11 3e. Colourless needles;
mp 124.0–124.4 ЊC (from CH2Cl2–hexane); vmax(KBr)/cmϪ1
2950, 2900, 1675, 1600, 1570, 1310, 1260, 1180 and 1140; δH (400
MHz, CDCl3) 2.44 (3 H, s), 3.89 (3 H, s), 4.66 (2 H, s), 6.95
(2 H, d, J 8.8), 7.33 (2 H, d, J 8.1), 7.75 (2 H, d, J 8.1) and 7.94
(2 H, d, J 8.8); δC(100 MHz, CDCl3) 22.0, 55.9, 63.9, 114.3,
128.9, 129.2, 130.1, 132.2, 136.0, 145.6, 164.8 and 186.6;
m/z 304 (M+), 240 and 135.
4-Methoxyphenacyl pentafluorophenyl sulfone 3f. Colourless
needles; mp 112.9–113.3 ЊC (from CH2Cl2–hexane); vmax(KBr)/
cmϪ1 3020, 2980, 2900, 1690, 1600, 1500, 1340, 1260 and 1170;
δH (400 MHz, CDCl3) 3.91 (3 H, s), 4.86 (2 H, s), 6.99 (2 H, d, J
6.8) and 7.92 (2 H, d, J 6.8); δC(100 MHz, CDCl3) 55.7, 63.1,
114.4, 128.2, 131.6, 165.1 and 185.8; δF (376 MHz, CDCl3)
136.67–136.80 (2 F, m), 143.77 (1 F, tt, J 21.4 and 7.5) and
159.11–159.28 (2 F, m); m/z 381 (M+ + 1), 317, 231, 167 and 134
(Found: C, 47.60; H, 2.30. Calc. for C15H9F5O4S: C, 47.38; H,
2.39%).
Methyl 4-methylphenacyl sulfone 3g. Colourless needles; mp
114.0–114.7 ЊC (from CH2Cl2–hexane; lit.,12 114–117 ЊC); vmax
-
Preparation of the silyl enol ethers 2g and 2h
(KBr)/cmϪ1 3000, 2940, 1660, 1600, 1420, 1320 and 1160;
δH (400 MHz, CDCl3) 2.44 (3 H, s), 3.14 (3 H, s), 4.58 (2 H, s),
7.32 (2 H, d, J 8.3) and 7.90 (2 H, d, J 8.3); δC(100 MHz,
CDCl3) 21.8, 41.7, 61.2, 129.4, 129.7, 133.1, 146.0 and 188.7;
m/z 212 (M+), 119 and 91.
3,3-Dimethyl-2-trimethylsilyloxybut-1-ene2gwasprepared from
3,3-dimethylbutan-2-one by the method reported in the liter-
ature;6 yield 33%. 2-Trimethylsilyloxyhept-1-ene2hwasprepared
according to the literature by treating heptan-2-one with LDA
in THF at Ϫ 78 ЊC and then adding trimethylchlorosilane to
the resultant lithium enolate of heptan-2-one.7
4-Methylphenacyl 4Ј-tolyl sulfone 3h. Colourless needles; mp
112.1–112.4 ЊC (from CH2Cl2–hexane; lit.,9 112 ЊC); vmax(KBr)/
cmϪ1 2960, 1670, 1610, 1310 and 1150; δH (400 MHz, CDCl3)
2.33 (3 H, s), 2.43 (3 H, s), 4.68 (2 H, s), 7.28 (2 H, d, J 8.3), 7.33
(2 H, d, J 8.3), 7.75 (2 H, d, J 8.3) and 7.85 (2 H, d, J 8.3); δC(100
MHz, CDCl3) 22.0, 22.1, 63.9, 128.9, 129.80, 129.83, 130.1,
133.7, 136.1, 145.6, 145.8 and 187.9; m/z 288 (M+), 225 and 120.
4-Methylphenacyl pentafluorophenyl sulfone 3i. Colourless
needles; mp 151.8–152.1 ЊC (from CH2Cl2–hexane); vmax(KBr)/
cmϪ1 2980, 2910, 1690, 1610, 1500, 1350 and 1150; δH (400
MHz, CDCl3) 2.45 (3 H, s), 4.89 (2 H, s), 7.32 (2 H, d, J 8.3) and
7.83 (2 H, d, J 8.3); δC(100 MHz, CDCl3) 22.1, 63.5, 129.5,
130.2, 133.0, 146.8 and 187.5; δF (376 MHz, CDCl3) 136.66–
136.79 (2 F, m), 144.0 (1 F, tt, J 22.0 and 7.1) and 159.03–159.22
(2 F, m); m/z 364 (M+), 344, 300, 168 and 119 (Found: C, 49.27;
H, 2.29. Calc. for C15H9F5O3S: C, 49.46; H, 2.49%).
4-Fluorophenacyl methyl sulfone 3j. Colourless needles; mp
112.5–113.4 ЊC (from CH2Cl2–hexane); vmax(KBr)/cmϪ1 3020,
1670, 1590, 1420, 1300, 1230 and 1140; δH (400 MHz, CDCl3)
3.15 (3 H, s), 4.57 (2 H, s), 7.21 (2 H, dd, J 7.8 and 7.8) and 8.06
(2 H, dd, J 7.8 and 5.4); δC(100 MHz, CDCl3) 41.7, 61.5, 116.3,
132.1, 132.3, 166.7 and 187.6; m/z 216 (M+), 201, 138 and 96;
δF (376 MHz, CDCl3) 102.80–102.88 (1 F, m) (Found: C, 50.04;
H, 4.11. Calc. for C9H9FO3S: C, 49.99; H, 4.20%).
4-Fluorophenacyl 4Ј-tolyl sulfone 3k. Colourless needles; mp
134.0–134.4 ЊC (from CH2Cl2–hexane); vmax(KBr)/cmϪ1 3010,
1680, 1600, 1420, 1290, 1230 and 1150; δH (400 MHz, CDCl3)
2.45 (3 H, s), 4.68 (2 H, s), 7.16 (2 H, dd, J 8.6 and 8.6), 7.34
(2 H, d, J 8.3), 7.75 (2 H, d, J 8.3) and 8.01 (2 H, dd, J 8.6 and
5.4); δC(100 MHz, CDCl3) 21.7, 63.7, 116.1, 128.5, 129.9, 131.5,
132.2, 135.6, 145.5, 166.4 and 186.5; δF (376 MHz, CDCl3)
103.52–103.60 (1 F, m); m/z 292 (M+), 226, 155, 123 and 95
(Found: C, 61.51; H, 4.35. Calc. for C15H13FO3S: C, 61.63; H,
4.48%).
General procedure for the reaction of sulfonyl chlorides with silyl
enol ethers
A solution containing the sulfonyl chloride 1 (2.0 mmol), silyl
enol ether 2 (2.0 mmol) and dichlorotris(triphenylphosphine)-
ruthenium() (0.02 mmol) in dry benzene (4.0 cm3) was
degassed by a freeze–pump–thaw cycle, sealed in an ampoule
and heated at 120 ЊC for 7 h.The reaction mixture was subjected
to column chromatography on Merck 7734 silica gel 60 with
hexane–ethyl acetate (5:1) as eluent. The product was further
purified by recrystallization from dichloromethane–hexane and
identified by IR, NMR and MS spectroscopy. The physical and
spectral data for the compounds obtained are as follows.
Methyl phenacyl sulfone 3a. Colourless needles; mp 106.7–
107.0 ЊC (from CH2Cl2–hexane; lit.,8 106–107 ЊC); vmax(KBr)/
cmϪ1 3000, 2950, 1680, 1300 and 1150; δH (400 MHz, CDCl3)
3.16 (3 H, s), 4.61 (2 H, s), 7.54 (2 H, dd, J 8.0 and 7.4), 7.67 (1
H, t, J 7.4) and 8.01 (2 H, d, J 8.0); δC(100 MHz, CDCl3) 41.8,
61.3, 129.1, 129.3, 134.8, 135.6 and 189.2; m/z 198 (M+), 105
and 77.
Phenacyl 4Ј-tolyl sulfone 3b. Colourless needles; mp 106.4–
106.8 ЊC (from CH2Cl2–hexane; lit.,9 108 ЊC); vmax(KBr)/cmϪ1
3000, 1680, 1320 and 1150; δH (400 MHz, CDCl3) 2.44 (3 H, s),
4.71 (2 H, s), 7.33 (2 H, d, J 8.3), 7.48 (1 H, dd, J 8.3 and 7.3),
7.61 (1 H, t, J 7.3), 7.76 (2 H, d, J 8.3) and 7.94 (2 H, d, J 8.3);
δC(100 MHz, CDCl3) 21.6, 63.5, 128.5, 128.8, 129.3, 129.8,
134.3, 135.7, 136.0, 145.3 and 188.1; m/z 274 (M+) and 211.
Pentafluorophenyl phenacyl sulfone 3c. Colourless needles; mp
141.4–142.5 ЊC (from CH2Cl2–hexane); vmax(KBr)/cmϪ1 3000,
2950, 1700, 1490, 1350, 1270, 1160 and 990; δH (400 MHz,
CDCl3) 4.29 (2 H, s), 7.52 (2 H, dd, J 8.3 and 7.3), 7.68 (1 H,
t, J 7.3) and 7.93 (2 H, d, J 8.3); δC(100 MHz, CDCl3) 63.1,
J. Chem. Soc., Perkin Trans. 1, 1997
785